References
- Y. Kanawaku, S. Someya, T. Kobayashi, K. Hirakawa, S. Shiotani, T. Fukunaga, Y. Ohno, S. Kawakami, and J. Kanetake, "High-resolution 3D-MRI of postmortem brain specimens fixed by formalin and gadoteridol", egMed(Tokyo) vol.16, no.4, pp.218-21, Jul, 2014.
- E. Hagberg, and K. Scheffler, "Effect of r(1) and r(2) relaxivity of gadolinium-based contrast agents on the T(1)-weighted MR signal at increasing magnetic field strengths", ContrastMediaMolImaging vol.8, no.6, pp. 456-65, Nov-Dec, 2013. https://doi.org/10.1002/cmmi.1565
- Z. Seidl, J. Vymazal, M. Mechl, M. Goyal, M. Herman, C. Colosimo, M. Pasowicz, R. Yeung, B. Paraniak-Gieszczyk, B. Yemen, N. Anzalone, A. Citterio, G. Schneider, S. Bastianello, and J. Ruscalleda, "Does higher gadolinium concentration play a role in the morphologic assessment of brain tumors? Results of a multicenter intraindividual crossover comparison of gadobutrol versus gadobenate dimeglumine (the MERIT Study)", AJNRAmJNeuroradiol, vol.33, no.6, pp.1050-8,Jun, 2012. https://doi.org/10.3174/ajnr.A3033
- H. S. Thomsen, S. K. Morcos, T. Almen, M. F. Bellin, M. Bertolotto, G. Bongartz, O. Clement, P. Leander, G. Heinz-Peer, P. Reimer, F. Stacul, A. van der Molen, J. A. Webb, and E. C. M. S. Committee, "Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines", EurRadiol, vol.23, no.2, pp.307-18, Feb, 2013. https://doi.org/10.1007/s00330-012-2597-9
- S. K. Morcos, "Nephrogenic systemic fibrosis following the administration of extracellular gadolinium based contrast agents: is the stability of the contrast agent molecule an important factor in the pathogenesis of this condition?", BrJRadiol,vol.80,no.950,pp.73-6, Feb, 2007. https://doi.org/10.1259/bjr/17111243
- F. G. Shellock, and A. Spinazzi, "MRI safety update 2008: part 1, MRI contrast agents and nephrogenic systemic fibrosis", AJRAm JRoentgenol, vol.191, no.4, pp.1129-39, Oct, 2008. https://doi.org/10.2214/AJR.08.1038.1
- A. Spinazzi, M. A. Kirchin, and G. Pirovano, "Nephrogenic systemic fibrosis: the need for accurate case reporting", JMagnResonImaging, vol.29, no.5, pp.1240; authorreply 1241, May, 2009.
- Min Hee Hong, M.D.1, Hyang Mo Koo, M.D.1, Junjeong Choi, M.D.2, Jung Ryun Ahn, M.D.1, Hong Jae Chon, M.D.1, Chan Kim, M.D.1, and Seung Tae Lee, M.D., Ph.D.1, "A case of nephrogenic systemic fibrosis after gadoliniumbased contrast agent injection" Departments of 1Internal Medicine and 2Pathology, Yonsei University College of Medicine, Seoul, Korea, vol.78, no.5, 2010
- Tae Hyoung Koo, M.D.1, Dong Hyun Lee, M.D.1, Hee Kyung Baek, M.D.1, Do Kyong Kim, M.D.1, Bo Kyung Kim, M.D.1, Suk Hee Hong, M.D.2, and Won Suk An, M.D.1, "A case of nephrogenic systemic fibrosis following gadolinium exposure in a peritoneal dialysis patient", Departments of 1Internal Medicine and 2Pathology, Dong-A University College of Medicine, Busan, Korea
- T. Kubota, K. Yamada, O. Kizu, T. Hirota, H. Ito, K. Ishihara, and T. Nishimura, "Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors", JMagnResonImaging, vol.21, no.6, pp.694-700, Jun, 2005.
- C. Zhu, U. Sadat, A. J. Patterson, Z. Teng, J. H. Gillard, and M. J. Graves, "3D high-resolution contrast enhanced MRI of carotid atheroma--a technical update", MagnResonImaging, vol.32, no.5, pp.594-7, Jun, 2014.
- S. J. Ahn, M. R. Yoo, S. H. Suh, S. K. Lee, K. S. Lee, E. J. Son, and T. S. Chung, "Gadolinium enhanced 3D proton density driven equilibrium MR imaging in the evaluation of cisternal tumor and associated structures: comparison with balanced fast-field-echo sequence", PLoSOne, vol.9, no.7, pp. e103215, 2014. https://doi.org/10.1371/journal.pone.0103215
- R. Jablonowski, D. Nordlund, M. Kanski, J. Ubachs, S. Koul, E. Heiberg, H. Engblom, D. Erlinge, H. Arheden, and M. Carlsson, "Infarct quantification using 3D inversion recovery and 2D phase sensitive inversion recovery; validation in patients and ex vivo", BMCCardiovascDisord, vol.13, pp.110, 2013.
- S. Kakite, S. Fujii, M. Kurosaki, Y. Kanasaki, E. Matsusue, T. Kaminou, and T. Ogawa, "Three-dimensional gradient echo versus spin echo sequence in contrast-enhanced imaging of the pituitary gland at 3T", EurJRadiol, vol.79, no.1, pp.108-12, Jul, 2011. https://doi.org/10.1016/j.ejrad.2009.12.036
- H. Fukuoka, T. Hirai, T. Okuda, Y. Shigematsu, A. Sasao, E. Kimura, T. Hirano, S. Yano, R. Murakami, and Y. Yamashita, "Comparison of the added value of contrast-enhanced 3D fluid-attenuated inversion recovery and magnetization-prepared rapid acquisition of gradient echo sequences in relation to conventional postcontrast T1-weighted images for the evaluation of leptomeningeal diseases at 3T", AJNRAmJNeuroradiol, vol.31, no.5, pp.868-73, May, 2010. https://doi.org/10.3174/ajnr.A1937
- S. G. Wetzel, G. Johnson, A. G. Tan, S. Cha, E. A. Knopp, V. S. Lee, D. Thomasson, and N. M. Rofsky, "Three-dimensional, T1-weighted gradient-echo imaging of the brain with a volumetric interpolated examination", AJNRAm JNeuroradiol, vol.23, no.6, pp.995-1002, Jun-Jul, 2002.
- M. J. Sharafuddin, A. H. Stolpen, S. Sun, C. R. Leusner, A. A. Safvi, J. J. Hoballah, W. J. Sharp, and J. D. Corson, "High-resolution multiphase contrast-enhanced three-dimensional MR angiography compared with two-dimensional time-of-flight MR angiography for the identification of pedal vessels," JVascInterv Radiol, vol.13, no.7, pp.695-702, Jul, 2002. https://doi.org/10.1016/S1051-0443(07)61846-6
- B. K. Kang, M.-O. Kim, T. Hong, and D.-H. Kim, "Facial Muscles 3D Modeling using Ultra-short Echo-time (UTE) Magnetic Resonance Imaging (MRI).pdf," IEIE, pp.4, July, 2013.
- M. Woo Kyung Moon, "MR Contrast Agents and Molecular maging", DepartmentofRadiology, College of Medicine, Seoul National University, 2004.
Cited by
- Gadoteridol's Signal Change according to TR, TE Parameters in T1 Image vol.52, pp.9, 2015, https://doi.org/10.5573/ieie.2015.52.9.117
- Comparative Analysis of Quantitative Signal Intensity between 1.0 mol and 0.5 mol MR Contrast Agent vol.52, pp.12, 2015, https://doi.org/10.5573/ieie.2015.52.12.134
- Optimization of Flip Angle at Head & Neck MR Angiography using Gadoteridol vol.53, pp.3, 2016, https://doi.org/10.5573/ieie.2016.53.3.151
- Signal Change of Iodinated Contrast Agents in MR Imaging vol.53, pp.12, 2016, https://doi.org/10.5573/ieie.2016.53.12.131
- 9.4T MRI FLASH Sequence에서 마우스의 뇌 조영증강 검사를 위한 적정 Echo phase vol.54, pp.7, 2017, https://doi.org/10.5573/ieie.2017.54.7.115